Current S3 guidelines on surgical treatment of gastric carcinoma;Aktuelle S3-Leitlinie zur Chirurgie des Magenkarzinoms

Chirurg

Volumn 83, Issue 1, 2012, Pages 31-37

  Meyer, H J ^a   Holscher A H ^b   Lordick, F ^c   Messmann, H ^d   Monig S ^b   Schumacher, C ^e   Stahl, M ^f   Wilke, H ^f   Mohler M ^g  

^a STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

^d KLINIKUM AUGSBURG   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f KLINIKEN ESSEN MITTE   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Esophagogastroduodenoscopy; Evidence; Gastric carcinoma; S3 guidelines; Staging

Indexed keywords

ADENOCARCINOMA; ADJUVANT THERAPY; ALGORITHM; ARTICLE; BIOPSY; CANCER STAGING; CHEMORADIOTHERAPY; CONSENSUS DEVELOPMENT; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; EVIDENCE BASED MEDICINE; GASTRECTOMY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPHADENECTOMY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROGNOSIS; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; ALGORITHMS; BIOPSY; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; EVIDENCE-BASED MEDICINE; GASTRECTOMY; GASTRIC MUCOSA; HUMANS; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; NEOPLASM STAGING; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84855979547     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2149-x     Document Type: Article

References (30)

1. Badgwell B, Cormier JN, Xing Y et al (2009) Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 16: 42-50.
2. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908-914.
3. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20.
4. Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 und D2 resection for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79: 1522-1530.
5. Englisch-Fritz C, Hünerbein M, Porschen R (2008) Diagnostik beim Magenkarzinom. Onkologe 14: 332-338.
6. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8: 226-234.
7. Gretschel S, Siegel R, Estevez-Schwarz L et al (2006) Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg 93: 1530-1535.
8. Grundmann RT, Hölscher AH, Bembenek A et al (2009) Diagnostik und Therapie des Magenkarzinoms - Workflow. Zentralbl Chir 134: 362-374.
9. Hartgrink HH, Velde CJ van de, Putter H et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22: 2069-2077.
10. Hermanek P (1995) pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 19: 184-190.
11. Hoelscher A, Drebber U, Moenig S et al (2009) Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg 250: 791-797.
12. Hosono S, Arimoto Y, Ohtani H et al (2006) Meta-analysis of short-term outcomes after laparoscopy-assisted distal gastrectomy. World J Gastroenterol 12: 7676-7683.
13. Isomoto H, Shikuwa S, Yamaguchi N et al (2009) Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 58: 331-336.
14. Ychou M, Boige V, Pignon JP et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29: 1715-1721.
15. Yokoi C, Gotoda T, Hamanaka H et al (2006) Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection. Gastrointest Endosc 64: 212-218.
16. Keoghley MRB (2003) Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 18: 7-30.
17. Kwee RM, Kwee TC (2007) Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 25: 2107-2116.
18. Lim S, Muhs BE, Marcus SG et al (2007) Results following resection for stage IV gastric cancer: are better outcomes observed in selected patient subgroups? J Surg Oncol 95: 118-122.
19. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730.
20. Meyer JH (2005) The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol 31: 595-604.
21. Moehler M, Al Batran SE, Andus T et al (2011) S3-Leitlinie "Magenkarzinom" - Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs. Z Gastroenterol 49: 461-531.
22. Power DG, Schattner MA, Gerdes H et al (2009) Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg 208: 173-178.
23. Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia and subcardia: randomised controlled trial. Lancet Oncol 7: 644-651.
24. Sasako M, Sano T, Yamamoto S et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359: 453-462.
25. Schumacher C, Gretschel S, Lordick F et al (2010) Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial. J Clin Oncol 28: 5210-5218.
26. Shirabe K, Shimada M, Matsumata T et al (2003) Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology 50: 1560-1563.
27. Songun I, Putter H, Kranenbarg EM et al (2010) Surgical treatment of gastric cancer: 15-years follow-up results of the randomised nationwide Dutch D1 D2 trial. Lancet Oncol 11: 439-449.
28. Siewert JR, Böttcher K, Stein HJ et al (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461.
29. Vliet EP van, Lugt A van der, Kuiper EJ et al (2007) Ultrasound, computed tomography, or the combination for the detection of supraclavicular lymph nodes in patients with oesophageal or gastric cardia cancer: a comparative study. J Surg Oncol 96: 200-206.
30. Voutilainen ME, Juhola MT (2005) Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur J Gastroenterol Hepatol 17: 1345-1349.